COMMUNIQUÉS West-GlobeNewswire

REPEAT - AgraFlora Organics Provides Guidance and Facility Expansion Updates at Toronto, ON Brewhouse; Increases Production Capacities by 30%
25/06/2019
VANCOUVER, British Columbia, June 25, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
Data Presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2019 Annual Meeting Highlights Potential of Progenics’ PSMA-Targeted Imaging Agent, PyL, in Detecting Prostate Cancer
25/06/2019
NEW YORK, June 25, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow cancer, today [...]
Cambrex Appoints Dottie Donnelly-Brienza as Senior Vice President and Chief Human Resources Officer
25/06/2019
EAST RUTHERFORD, N.J., June 25, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]
Medexus Appoints Accomplished Global Pharmaceutical Industry Executive Adele M. Gulfo to its Board of Directors
25/06/2019
MONTREAL, June 25, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF), a leading specialty pharmaceutical company with a strong North American commercial [...]
HealthLynked Streamlines Patient Check-in with the Release of its New Application for Healthcare Practices
25/06/2019
NAPLES, Fla., June 25, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp (OTCQB: HLYK ), a leading digital healthcare company, today released its new application that provides a secure solution to one of healthcare’s most [...]
VPR Brands Provides Update on International Sales Progress
25/06/2019
· HoneyStick brand now available in EU with its newest distributor Near Dark in Germany · HoneyStick brand now available in Chile through AllGrano Distribución · HoneyStick brand now available direct to consumer on [...]
Auxly Announces Appointment of Andrew MacMillan as VP, Commercial Business Development
25/06/2019
VANCOUVER, British Columbia, June 25, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce the appointment of Andrew MacMillan as Vice President, [...]
Immutep Completes Patient Enrolment of the AIPAC Phase IIb Clinical Trial in Metastatic Breast Cancer
25/06/2019
226 patients with metastatic breast cancer have been enrolled in the AIPAC study Combination of eftilagimod alpha, an antigen presenting cell (APC) activator, administered in combination with chemotherapy is designed to [...]
Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET® (avatrombopag) for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease
25/06/2019
-Approval Based on Positive Efficacy and Safety Data from Two Phase 3 Clinical Trials- -Company Intends to Partner for the European Commercialization of DOPTELET- DURHAM, N.C., June 25, 2019 (GLOBE NEWSWIRE) -- Dova [...]
Predictive Technology Group Announces the Presentation of New Data Demonstrating the Genetic Basis of Endometriosis at ESHRE
25/06/2019
SALT LAKE CITY, June 25, 2019 (GLOBE NEWSWIRE) -- Predictive Laboratories, a wholly owned subsidiary of Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease [...]
Progressive Care Inc. Announces Steady Sales Growth in May
25/06/2019
MIAMI, June 25, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of [...]
Rafael Pharmaceuticals Enters into Out-Licensing Agreement with Ono Pharmaceutical to Accelerate Clinical Development and Commercialization of Cancer Drug Candidate CPI-613® (devimistat) in Japan and Other Asian Countries
25/06/2019
Cranbury, NJ, June 25, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced today that it has entered into [...]
Samuel E. Navarro Appointed to BioSig Board of Directors
25/06/2019
Successful investment banker and medical device industry veteran to join the Company as Independent Director Santa Monica, CA, June 25, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device [...]
Tauriga Sciences Inc. Presentation Today at 3:30-4:00pm EST at The MJ Micro Conference in Midtown Manhattan
25/06/2019
New York, NY, June 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
Akorn Receives FDA Warning Letter
25/06/2019
LAKE FOREST, Ill., June 25, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that it received a warning letter from the U.S. Food and Drug Administration [...]
CB2 Insights Expands Clinical Division into New Jersey with the Asset Acquisition of New Jersey Alternative Medicine Clinics
25/06/2019
CB2 Brand Canna Care Docs Assumes Continuity of Care for 100% of Large New Jersey Medical Cannabis Evaluation Clinic Group TORONTO, June 25, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “ [...]
Harrow Health Adds Two Senior Executives to its Nashville Team
25/06/2019
NASHVILLE, Tenn., June 25, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it has promoted Dennis Saadeh, PharmD as its Chief of Formulation Strategy and has hired Larry Dillaha, MD as [...]
Myriad Announces Publication of First Comprehensive Economic Study Demonstrating Cost Effectiveness of EndoPredict® for Breast Cancer
25/06/2019
Findings Show EndoPredict Was Significantly More Cost Effective than Oncotype DX™ SALT LAKE CITY, June 25, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today [...]
Anavex Life Sciences Announces First Patient Dosed in Extension Study to its U.S. Phase 2 Clinical Trial of ANAVEX®2-73 in Patients for Rett Syndrome
25/06/2019
NEW YORK, June 25, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]

Pages